Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes

Molecular Pharmacology

Volumn 57, Issue 1, 2000, Pages 188-197

  Schuetz, Erin G ^a   Umbenhauer, Diane R ^b   Yasuda, Kazuto ^a   Brimer, Cynthia ^a   Nguyen, Lan ^a   Relling, Mary V ^a   Schuetz, John D ^a   Schinkel, Alfred H ^c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; MIDAZOLAM; SPHINGOLIPID ACTIVATOR PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG ELIMINATION; DRUG HYDROXYLATION; FEMALE; GENOTYPE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIVER; MALE; MICE; MICE, KNOCKOUT; NADPH-FERRIHEMOPROTEIN REDUCTASE; NETHERLANDS; OXIDOREDUCTASES, N-DEMETHYLATING; P-GLYCOPROTEIN; UNITED STATES;

EID: 0033984216     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Abdel-Razzak Z, Loyer P, Fautrel A, Gautier J-C, Corcos L, Turlin B, Beaune P and Guillouzo A (1993) Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 44:707-715.
2. Barnes KM, Dickstein B, Cutler GB, Fojo T and Bates SE (1996) Steroid transport, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells. Biochemistry 35:4820-4827.
3. Beaune P, Kremers P, Letawe-Goujon F and Gielen JE (1985) Monoclonal antibodies against human liver cytochrome P-450. Biochem Pharmacol 34:3547-3552.
4. Blumberg B, Sabbagh W, Juguilon H, Bolado J, van Meter CM, Ong ES and Evans RM (1998) SXR, a novel steroid and xenobiotic sensing nuclear receptor. Genes Dev 12:3195-3205.
5. Boettger-Tong H, Murthy L, Chiappetta C, Kirkland JL, Goodwin B, Adlercreutz H, StanceL GM and Makela S (1998) A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens. Environ Health Perspect 106:369-373.
6. Bornheim LM and Correia MA (1990) Selective inactivation of mouse liver cytochrome P-450IIIA by cannabidiol. Mol Pharmacol 38:319-326.
7. Drach J, Gsur A, Hamilton G, Zhao S, Angerler J, Fiegl M, Zojer N, Raderer M, Haberl I, Andereeff M and Huber H (1996) Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Blood 88:1747-1754.
8. Dwarki VJ, Francis V, Bhat GJ and Padmanaban G (1987) Regulation of cytochrome P-450 messenger RNA and apoprotein levels by heme. J Biol Chem 262:16958-16962.
9. Harvey M, McArthur MJ, Montgomery CA, Bradley A and Donehower LA (1993) Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J 7:938-943.
10. Hashimoto H, Toide K, Kitamura R, Fujita M, Tagawa S, Itoh S and Kamataki T (1993) Gene structure of CYP3A4, an adult -specific form of cytochrome P450 in human livers, and its transcriptional control. Eur J Biochem 218:585-595.
11. Hostetler KA, Wrighton SA, Kremers P and Guzelian PS (1987) Immunochemical evidence for multiple steroid-inducible hepatic cytochromes P-450 in the rat. Biochem J 245:27-33.
12. Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterstrom RH, Perlmann T and Lehmann JM (1998) An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92:73-82.
13. Kralli A, Bohen SP and Yamamoto KR (1995) LEM1, an ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones. Proc Natl Acad Sci USA 92:4701-4705.
14. Kwei GY, Alvaro RF, Chen Q, Jenkins HJ, Hop CEAC, Keohane CA, Strauss JR, Wang RW, Wang TR, Pippert TR and Umbenhauer DR (1999) Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein. Drug Metab Dispos 27:581-587.
15. Lown KS, Mayo RR, Leichtman AB, Hsiao H-I, Turgeon DK, Ren P, Brown MB, Guo W, Rossi SJ, Benet LZ and Watkins PB (1997) Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther 62:248-260.
16. Mathis JM, Houser WH, Bresnick E, Cidlowski JA, Hines RN, Prough RA and Simpson ER (1989) Glucocorticoid regulation of the rat cytochrome P450c (P4501A1) gene: Receptor binding within intron 1. Arch Biochem Biophys 269:93-105.
17. Meijer OC, de Lange ECM, Breimer DD, de Boer AG, Workel JO and de Kloet ER (1998) Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1a P-glycoprotein Knockout Mice. Endocrinology 139:1789-1793.
18. Nemoto N and Sakurai J (1995) Glucocorticoid and sex hormones as activating or modulating factors for expression of Cyp2b-9 and Cyp2b-10 in the mouse liver and hepatocytes. Arch Biochem Biophys 319:286-292.
19. Perloff MD, von Moltke LL, Cotreau MM and Greenblatt DJ (1999) Unchanged cytochrome P450 3A (CYP3A) Expression and metabolism of midazolam, triazolam, and dexamethasone in mdr (-/-) mouse liver microsomes. Biochem Pharmacol 57:1227-1232.
20. Piekarz RL, Cohen D and Horwitz SB (1993) Progesterone regulates the murine multidrug resistance mdr1b gene. J Biol Chem 268:7613-7616.
21. Ribeiro RCJ, Cavalieri RR, Lomri N, Rahmaoui CM, Baster JD and Scharschmidt BF (1996) Thyroid hormone export regulates cellular hormone content and response. J Biol Chem 271:17147-17151.
22. Schinkel AH, Smit JJM, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus-Maandag EC, te Riele HPJ, Berns AJM and Borst P (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502.
23. Schinkel AH, Wagenaar E, van Deemter L, Mol C and Borst P (1995) Absence of the mdr1a p-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporin A. J Clin Invest 96:1698-1705.
24. Schinkel AH, Mayer U, Wagenaar E, Mol CAAM, van Deemter L, Smit JJM, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans J, Fibbe WE and Borst P (1997) Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 94:4028-4033.
25. Schmidt JV, Huei-Ting Su G, Reddy JK, Simon MC and Bradfield CA (1996) Characterization of a murine Ahr null allele: Involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci USA 93:6731-6736.
26. Schuetz EG, Beck WT and Schuetz JD (1996a) Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol Pharmacol 49:311-318.
27. Schuetz EG, Furuya KN and Schuetz JD (1995) Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J Pharmacol Exp Ther 275:1011-1018.
28. Schuetz EG and Guzelian PS (1984) Induction of cytochrome P-450 by glucocorticoids in rat liver. II. Evidence that glucocorticoids regulate induction of cytochrome P-450 by a nonclassical receptor mechanism. J Biol Chem 259:2007-2012.
29. Schuetz EG, Li D, Omiecinski CJ, Muller-Eberhard U, Kleinman HK, Elswick B and Guzelian PS (1988) Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. J Cell Physiol 134:309-323.
30. Schuetz EG, Schinkel AH, Relling MV and Schuetz JD (1996b) P-glycoprotein: A major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans. Proc Natl Acad Sci USA 93:4001-4005.
31. Schuetz EG, Schmid W, Schutz G, Brimer C, Yasuda K, Kamataki T, Bornheim L, Myles K and Cole TJ (1999) The glucocorticoid receptor is essential for induction of cytochrome P4502B by steroids but not for drug or steroid induction of CYP3A or P450 reductase in mouse liver. Drug Metab Dispos, in press.
32. Schuetz EG, Schuetz JD, Grogan WM, Toth A, Toth G, Rauch J, Guzelian P, Gionela K and Watlington CO (1992) Expression of cytochrome P4503A in amphibian, rat and human kidney. Arch Biochem Biophys 294:206-214.
33. Schuetz EG, Wrighton SA, Safe SH and Guzelian PS (1986) Regulation of cytochrome P-450p by phenobarbital and phenobarbital-like inducers in adult rat hepatocytes in primary monolayer culture and in vivo. Biochemistry 25:1124-1133.
34. Strom SC, Pisarov LA, Dorko K, Thompson MT, Schuetz JD and Schuetz EG (1996) The use of human hepatocytes to study P450 gene induction. Methods Enzymol 272:388-400.
35. Thai C, Kahwaji JE, Loeper J, Tinel M, Doostzadeh J, Labbe G, Leclaire J, Beaune P and Pessayre D (1994) Administration of high doses of human recombinant interleukin-2 decreases the expression of several cytochromes P-450 in the rat. J Pharmacol Exp Ther 268:515-521.
36. Tonjes RR, Xanthopoulos KG, Darnell JE and Paul D (1992) Transcriptional control in hepatocytes of normal and c14CoS albino deletion mice. EMBO (Eur Mol Biol Organ) J 11:127-133.
37. Umbenhauer DR, Lankas GH, Pippert TR, Wise LD, Cartwright MA, Hall SA and Beare CM (1997) Identification of a P-glycoprotein-deficient subpopulation in the CF-1 mouse strain using a restriction fragment length polymorphism. Toxicol Appl Pharmacol 146:88-94.
38. Watchko JF, Daood MJ and Hansen TWR (1998) Brain bilirubin content is increased in P-glycoprotein-deficient transgenic null mutant mice. Pediatr Res 44: 763-766.
39. Watkins PB, Wrighton SA, Maurel P, Schuetz EG, Mendez-Picon G, Parker GA andGuzelian PS (1985) Identification of an inducible form of cytochrome P-450 in human liver. Proc Natl Acad Sci USA 82:6310-6314.
40. Wrighton SA, Schuetz EG, Watkins PB, Maurel P, Barwick J, Bailey BS, Hartle HT, Young B and Guzelian P (1985) Demonstration in multiple species of inducible hepatic cytochromes P-450 and their mRNAs related to the glucocorticoid-inducible cytochrome P-450 of the rat. Mol Pharmacol 28:312-321.